Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
13F holders, Q1 2022
Institutional positions in Silence Therapeutics plc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +4 vs. Q4 2021
- Shares held
- 12.2M
- +1.84M (+17.8%) vs. Q4 2021
- Total value
- $218.3M
- −$28.4M (−11.5%) vs. Q4 2021
- New holders
- 7
- 4 more added
- Sold out
- 3
- 6 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $236.2M |
| Q1 2026 | 56 | $102.1M |
| Q4 2025 | 58 | $106.1M |
| Q3 2025 | 54 | $96.4M |
| Q2 2025 | 55 | $108.0M |
| Q1 2025 | 59 | $60.6M |
| Q4 2024 | 65 | $168.2M |
| Q3 2024 | 69 | $493.1M |
| Q2 2024 | 71 | $502.1M |
| Q1 2024 | 64 | $588.0M |
| Q4 2023 | 34 | $343.9M |
| Q3 2023 | 28 | $187.6M |
| Q2 2023 | 29 | $101.8M |
| Q1 2023 | 29 | $110.2M |
| Q4 2022 | 27 | $275.7M |
| Q3 2022 | 29 | $183.4M |
| Q2 2022 | 25 | $116.4M |
| Q1 2022 | 26 | $218.3M |
| Q4 2021 | 22 | $246.6M |
| Q3 2021 | 7 | $39.4M |
| Q2 2021 | 6 | $56.4M |
| Q1 2021 | 6 | $55.9M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Silence Therapeutics plc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lombard Odier Asset Management (USA) Corp | 3,632,234 | $55.7M | 9.74% | +159,713+4.6% | Added |
| Lombard Odier Asset Management (Europe) Ltd | 1,561,551 | $29.7M | 1.14% | +1,561,551 | New |
| Goldman Sachs Group Inc | 965,815 | $18.4M | 0.00% | +205,815+27.1% | Added |
| Deep Track Capital, LP | 951,580 | $18.1M | 1.17% | +782+0.1% | Added |
| Frazier Life Sciences Management, L.P. | 881,173 | $16.7M | 1.43% | +881,173 | New |
| BVF Inc | 666,666 | $12.7M | 0.51% | 00.0% | Unchanged |
| AXA S.A. | 661,666 | $12.6M | 0.04% | 00.0% | Unchanged |
| Consonance Capital Management LP | 654,108 | $12.4M | 21.08% | −104,145−13.7% | Reduced |
| Adage Capital Partners GP, L.L.C. | 550,000 | $10.4M | 0.02% | 00.0% | Unchanged |
| Great Point Partners LLC | 444,443 | $8.44M | 2.04% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 250,000 | $4.75M | 0.02% | 00.0% | Unchanged |
| HSBC Holdings PLC | 177,834 | $3.47M | 0.00% | −1,456−0.8% | Reduced |
| Cantor Fitzgerald, L. P. | 173,725 | $3.30M | 0.25% | −80,794−31.7% | Reduced |
| Morgan Stanley | 151,666 | $2.88M | 0.00% | −15,188−9.1% | Reduced |
| Altium Capital Management LP | 109,000 | $2.07M | 0.72% | +109,000 | New |
| SG Americas Securities, LLC | 101,445 | $1.93M | 0.02% | −400−0.4% | Reduced |
| UBS Group AG | 69,368 | $1.32M | 0.00% | −850−1.2% | Reduced |
| Citigroup Inc | 58,333 | $1.11M | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 56,125 | $1.07M | 0.00% | +99+0.2% | Added |
| Bellevue Group AG | 46,666 | $887.0K | 0.01% | 00.0% | Unchanged |
| Legal & General Group Plc | 14,973 | $288.0K | 0.00% | +14,973 | New |
| Deutsche Bank AG | 3,953 | $75.0K | 0.00% | +3,953 | New |
| Bank of America Corp | 770 | $15.0K | 0.00% | +770 | New |
| Steward Partners Investment Advisory, LLC | 100 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 117 | $2.00K | 0.00% | +117 | New |
| TCI Wealth Advisors, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Frazier Management LLC | 0 | $0 | 0.00% | −886,173−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −6,730−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −184−100.0% | Sold out |